ACRS R&D Expenses
Aclaris Therapeutics Inc · R&D Expenses
ACRS R&D Expenses
Latest reported$64.12Mperiod ending
ACRS TTM R&D Expenses ($6.51M → $64.12M)
TTM R&D Expenses
High-resolution chart · PNG
ACRS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 64,119,000 | |
| 56,718,000 | |
| 52,645,000 | |
| 45,087,000 | |
| 38,015,000 | |
| 35,325,000 | |
| 33,586,000 | |
| 51,206,000 | |
| 69,126,000 | |
| 85,642,000 | |
| 98,384,000 | |
| 92,810,000 | |
| 92,590,000 | |
| 86,094,000 | |
| 77,813,000 | |
| 70,843,000 | |
| 61,163,000 | |
| 50,281,000 | |
| 43,813,000 | |
| 38,666,000 | |
| 30,930,000 | |
| 29,499,000 | |
| 29,338,000 | |
| 31,948,000 | |
| 41,891,000 | |
| 53,047,000 | |
| 65,289,000 | |
| 73,261,000 | |
| 73,009,000 | |
| 69,371,000 | |
| 63,058,000 | |
| 56,710,000 | |
| 51,643,000 | |
| 45,624,000 | |
| 39,790,000 | |
| 33,544,000 | |
| 29,842,000 | |
| 31,713,000 | |
| 33,476,000 | |
| 28,935,000 | |
| 31,181,000 | |
| 23,138,000 | |
| 15,340,000 | |
| 14,992,000 | |
| 7,681,000 | |
| 7,066,000 | |
| 6,507,000 |